Schizophrenia Research

Deficits in gray matter volume are present in schizophrenia but not bipolar disorder
pp. 85-92(8)
Authors: Zipursky R.B.; Seeman M.V.; Bury A.; Langevin R.; Wortzman G.; Katz R.

Gene expression and neuronal activity in schizophrenia: a study of polyadenylated mRNA in the hippocampal formation and cerebral cortex
pp. 93-102(10)
Authors: Harrison P.J.; Burnet P.W.J.; Falkai P.; Bogerts B.; Eastwood S.L.

No differences in phospholipase-A₂ activity between acute psychiatric patients and controls
pp. 103-105(3)
Authors: Katila H.; Appelberg B.; Rimon R.

Reduced auditory P300 amplitude, medial temporal volume reduction and psychopathology in schizophrenia
pp. 107-115(9)
Authors: Kawasaki Y.; Maeda Y.; Higashima M.; Nagasawa T.; Koshino Y.; Suzuki M.; Ide Y.

Childhood laterality and later risk of schizophrenia in the 1946 British birth cohort
pp. 117-120(4)
Authors: Cannon M.; Jones P.; Murray R.M.; Wadsworth M.E.J.

Maternal exposure to influenza and paranoid schizophrenia
pp. 121-125(5)
Authors: Grech A.; Takei N.; Murray R.M.

Performance on tests sensitive to impaired executive ability in schizophrenia, mania and well controls: acute and subacute phases
pp. 127-137(11)
Authors: McGrath J.; Scheldt S.; Welham J.; Clair A.

Attentional and eye tracking deficits correlate with negative symptoms in schizophrenia
pp. 139-146(8)
Authors: Lees Roitman S.E.; Keefe R.S.E.; Harvey P.D.; Siever L.J.; Mohs R.C.

No deficit in Wisconsin Card Sorting Test performance of schizophrenic patients' first-degree relatives
pp. 147-151(5)
Authors: Stratta P.; Daneluzzo E.; Mattei P.; Bustini M.; Casacchia M.; Rossi A.

Context memory in schizoaffective and schizophrenic disorders
pp. 153-161(9)
Authors: Manschreck T.C.; Maher B.A.; Beaudette S.M.; Redmond D.A.

Utility of WAIS-R short forms in schizophrenia
pp. 163-172(10)
Authors: Allen D.N.; Huegel S.G.; Gurklis J.A.; Kelley M.E.; Barry E.J.; van Kammen D.P.

Normal neurocognitive performance after extended practice in patients with schizophrenia
pp. 173-180(8)
Authors: Wexler B.E.; Hawkins K.A.; Rounsaville B.; Anderson M.; Sernyak M.J.; Green M.F.

Violence in schizophrenia: role of hallucinations and delusions
pp. 181-190(10)
Authors: Cheung P.; Schweitzer I.; Crowley K.; Tuckwell V.

Olfactory identification deficit in relation to schizotypy
pp. 191-197(7)
Authors: Park S.; Schoppe S.

Temporal stability of polydipsia-hyponatremia
pp. 199-202(4)
Authors: Schnur D.B.; Frick S.; Smith S.

Awareness of own and others' schizophrenic illness
pp. 203-211(9)
Author: Startup M.

Working memory and the syndromes of schizotypal personality
pp. 213-220(8)
Authors: Park S.; McTigue K.

In vivo immunomodulatory effects of clozapine in schizophrenia
pp. 221-225(5)
Authors: Maes M.; Bosmans E.; Kenis G.; De Jong R.; Smith R.S.; Meltzer H.Y.

A differential role for interleukin-6 and tumor necrosis factor- in schizophrenia?
pp. 227-233(7)
Authors: Naudin J.; Capo C.; Giusano B.; Mege J.L.; Azorin J.M.

The inter-relationships of tardive dyskinesia, parkinsonism, akathisia and tardive dystonia: the Curacao Extrapyramidal Syndromes Study II
pp. 235-242(8)
Authors: van Harten P.N.; Hoek H.W.; Matroos G.E.; Koeter M.; Kahn R.S.

High prevalence of Helicobacter pylori in institutionalized schizophrenic patients
pp. 243-244(2)
Authors: De Hert M.; Hautekeete M.; De Wilde D.; Peuskens J.